Accutar Biotechnology

Provider of artificial intelligence-based solutions for accelerating drug discovery and development processes

placeBrooklyn, New York, United States calendar_todayFounded 2015 groups37 employees language accutarbio.com

Investor mix

8 investors on record; lead investors include Primavera, CDH, IDG Capital, Yunfeng Capital.

Investor typeCountShare
Venture capital113%
Private equity675%
Other / undisclosed113%
Coming soon